Ophthalmic Devices - South Africa

The Ophthalmic Devices market market in South Africa is forecasted to achieve a revenue of US$230.20m in 2024.
It is anticipated that the revenue will demonstrate a compound annual growth rate (CAGR 2024-2029) of 4.49%, leading to a market volume of US$286.80m by 2029.
When compared globally, the United States is expected to generate the highest revenue of US$14.00bn in 2024.
The demand for ophthalmic devices in South Africa is growing rapidly due to the increasing prevalence of eye diseases and the rising aging population.

Definition:
Ophthalmic devices refer to medical devices used for diagnosis of eye diseases, related surgeries, and vision correction.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B) as well as governments (B2G). Revenues are allocated to the country where the money is spent.

Company examples: Essilor International, Johnson & Johnson, Bausch Health Companies. Further information on the key players can be found in the Market Shares boxes.

Ophthalmology diagnostic & surgical devices
Vision care

Ophthalmology pharmaceuticals
Ophthalmology supplements

The Ophthalmic Devices market in South Africa has been experiencing steady growth in recent years, driven by a combination of customer preferences, market trends, local special circumstances, and underlying macroeconomic factors. Customer preferences in South Africa have played a significant role in the development of the Ophthalmic Devices market. With an aging population and an increasing prevalence of eye disorders, there is a growing demand for ophthalmic devices such as contact lenses, spectacles, and surgical instruments. Additionally, consumers are becoming more aware of the importance of eye health and are willing to invest in high-quality ophthalmic devices to improve their vision. Trends in the market have also contributed to its growth. Technological advancements in ophthalmic devices have led to the development of innovative products that offer improved accuracy, comfort, and convenience. For example, the introduction of advanced laser eye surgery techniques has revolutionized the treatment of refractive errors, leading to a surge in demand for related surgical instruments and equipment. Furthermore, the increasing adoption of telemedicine and online retail channels has made ophthalmic devices more accessible to consumers, driving market growth. Local special circumstances in South Africa have also influenced the development of the Ophthalmic Devices market. The country has a well-established healthcare infrastructure, with a large number of ophthalmic clinics and hospitals offering specialized eye care services. This has created a conducive environment for the growth of the market, as healthcare professionals have access to the necessary resources and expertise to diagnose and treat eye conditions. Additionally, the government has implemented initiatives to promote eye health and provide affordable eye care services to underserved populations, further driving the demand for ophthalmic devices. Underlying macroeconomic factors have also played a role in the development of the market. South Africa has experienced steady economic growth in recent years, leading to an increase in disposable income and healthcare expenditure. As a result, consumers are more willing to spend on ophthalmic devices to improve their quality of life. Furthermore, the country has a large and growing middle class, which has contributed to the expanding consumer base for ophthalmic devices. In conclusion, the Ophthalmic Devices market in South Africa is developing due to customer preferences, market trends, local special circumstances, and underlying macroeconomic factors. With an aging population, increasing prevalence of eye disorders, and technological advancements in ophthalmic devices, the market is expected to continue its growth trajectory in the coming years.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.